NASDAQ:AMYT

Amryt Pharma Stock Forecast, Price & News

$12.60

0.00 (0.00 %)

(As of 10/21/2020 12:00 AM ET)

Add

Compare

Today's Range

$12.60

Now: $12.60▼

$12.60

50-Day Range

$10.83

MA: $12.18▼

$13.50

52-Week Range

$10.06

Now: $12.60▼

$15.50

Volume12 shs

Average Volume28,044 shs

Market Capitalization$432.67 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

There is no company description available for Amryt Pharma Holdings Ltd.

Beat the Market (BTM) Rank^™

3.3 Analyst's Opinion

Consensus Rating
Amryt Pharma has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $42.50, Amryt Pharma has a forecasted upside of 237.3% from its current price of $12.60.
Amount of Analyst Coverage
Amryt Pharma has only been the subject of 2 research reports in the past 90 days.

2.5 Community Rank

Outperform Votes
Amryt Pharma has received 3 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Amryt Pharma has received 3 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Amryt Pharma has received 50.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Amryt Pharma and other stocks. Vote “Outperform” if you believe AMYT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AMYT will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Amryt Pharma does not currently pay a dividend.
Dividend Growth
Amryt Pharma does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Amryt Pharma insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Amryt Pharma are expected to grow in the coming year, from ($2.76) to ($1.60) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Amryt Pharma is -14.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Amryt Pharma is -14.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Overall Beat the Market Rank^™

1.28 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Pharmaceutical preparations

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:AMYT

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.amrytpharma.com

Phone353-1518-0200

EmployeesN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$58.12 million

Price / Sales7.44

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares34,339,000

Market Cap$432.67 million

Next Earnings Date11/5/2020 (Estimated)

OptionableNot Optionable

$12.60

0.00 (0.00 %)

(As of 10/21/2020 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive AMYT News and Ratings via Email

Sign-up to receive the latest news and ratings for AMYT and its competitors with MarketBeat's FREE daily newsletter.

Amryt Pharma (NASDAQ:AMYT) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Amryt Pharma?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amryt Pharma in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Amryt Pharma.

When is Amryt Pharma's next earnings date?

Amryt Pharma is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Amryt Pharma.

How were Amryt Pharma's earnings last quarter?

Amryt Pharma Holdings Ltd (NASDAQ:AMYT) released its quarterly earnings results on Thursday, August, 6th. The company reported ($0.12) EPS for the quarter. The company earned $46.19 million during the quarter.
View Amryt Pharma's earnings history.

What price target have analysts set for AMYT?

2 brokers have issued twelve-month target prices for Amryt Pharma's stock. Their forecasts range from $40.00 to $45.00. On average, they expect Amryt Pharma's share price to reach $42.50 in the next twelve months. This suggests a possible upside of 237.3% from the stock's current price.
View analysts' price targets for Amryt Pharma.

Who are some of Amryt Pharma's key competitors?

Some companies that are related to Amryt Pharma include Kura Oncology (KURA), Prestige Consumer Healthcare (PBH), Cryoport (CYRX), Intra-Cellular Therapies (ITCI), Zentalis Pharmaceuticals (ZNTL), Viela Bio (VIE), Y-mAbs Therapeutics (YMAB), ZEALAND PHARMA/S (ZEAL), ALX Oncology (ALXO), Amneal Pharmaceuticals (AMRX), Revance Therapeutics (RVNC), CytoDyn (CYDY), Rocket Pharmaceuticals (RCKT), Trillium Therapeutics (TRIL) and Northwest Biotherapeutics (NWBO).
View all competitors.

What other stocks do shareholders of Amryt Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amryt Pharma investors own include Immunic (IMUX), Ampio Pharmaceuticals (AMPE), Chimerix (CMRX), Livongo Health (LVGO), Otonomy (OTIC), Akero Therapeutics (AKRO), Albireo Pharma (ALBO), Aldeyra Therapeutics (ALDX), Advanced Micro Devices (AMD) and Applied DNA Sciences (APDN).

What is Amryt Pharma's stock symbol?

Amryt Pharma trades on the NASDAQ under the ticker symbol "AMYT."

How do I buy shares of Amryt Pharma?

Shares of AMYT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Amryt Pharma's stock price today?

One share of AMYT stock can currently be purchased for approximately $12.60.

How big of a company is Amryt Pharma?

Amryt Pharma has a market capitalization of $432.67 million and generates $58.12 million in revenue each year.

What is Amryt Pharma's official website?

The official website for Amryt Pharma is www.amrytpharma.com.

How can I contact Amryt Pharma?

Amryt Pharma's mailing address is DEPT 920A 196 HIGH ROAD WOOD GREEN, LONDON X0, D02 CR98. The company can be reached via phone at 353-1518-0200 or via email at [email protected]

This page was last updated on 10/22/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings